Tetratherix (ASX:TTX) EBIT: A$-11.34 Mil (TTM As of Dec. 2025)


ASX:TTX Tetratherix Ltd ASX:TTX
15 GF Score
Price A$6.12
View Full Analysis

What is Tetratherix EBIT?

Tetratherix ASX:TTX -1.45% 15 EBIT is A$-11.34 Mil as of Dec. 2025. GuruFocus rates ASX:TTX with a GF Score™ of 15/100.

Tetratherix's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was A$-4.57 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-11.34 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Tetratherix's annualized ROC % for the quarter that ended in Dec. 2025 was -147.43%. Tetratherix's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -129.06%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Tetratherix's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -3.56%.

Tetratherix  (ASX:TTX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Tetratherix's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-12.352 * ( 1 - 0% )/( (1.254 + 15.502)/ 2 )
=-12.352/8.378
=-147.43 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=31.833 - 2.199 - ( 29.337 - max(0, 2.526 - 30.906+29.337))
=1.254

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=38.056 - 0.991 - ( 21.563 - max(0, 2.063 - 25.034+21.563))
=15.502

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Tetratherix's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-9.142/( ( (0.886 + max(-2.139, 0)) + (11.299 + max(1.982, 0)) )/ 2 )
=-9.142/( ( 0.886 + 13.281 )/ 2 )
=-9.142/7.0835
=-129.06 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.341) - (2.199 + 0 + 0.281)
=-2.139

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.47 + 0 + 0.0010000000000012) - (0.991 + 0 + 0.498)
=1.982

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Tetratherix's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-11.342/318.998
=-3.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix EBIT Related Terms

Tetratherix EBIT Historical Data

* Premium members only.

The historical data trend for Tetratherix's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix EBIT Chart

Tetratherix Annual Data
Trend Jun23 Jun24 Jun25
EBIT
-3.84 -4.40 -9.36

Tetratherix Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial -2.26 -2.14 -2.59 -6.77 -4.57

ASX:TTX vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Tetratherix's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tetratherix EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tetratherix's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tetratherix's EV-to-EBIT falls into.


ASX:TTX
15GF Score
Tetratherix Ltd ASX:TTX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tetratherix EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-11.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of A$-11.34 Mil mean?
Tetratherix (ASX:TTX) has a EBIT of A$-11.34 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tetratherix.
Is Tetratherix's EBIT too high?
Tetratherix's current EBIT is A$-11.34 Mil. Overall, Tetratherix has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's EBIT compare to VRTX and REGN?
Tetratherix's EBIT of A$-11.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tetratherix. Tetratherix's current EBIT is A$-11.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current EBIT of A$-11.34 Mil. The current EBIT is A$-11.34 Mil. Tetratherix's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current EBIT is A$-11.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tetratherix Business Description

Address 34-36 Ralph Street, Unit 29, Alexandria, Sydney, NSW, AUS, 2015
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
15GF Score

Get the complete analysis for ASX:TTX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.12
Price